Reaction
Vulvovaginal Erythema reporting signals
As of the last recalculation, Vulvovaginal Erythema appears in 820 FAERS reports alongside 11 co-occurring drug terms. The strongest observed disproportionality signal is MICONAZOLE NITRATE (PRR 369.3).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Miconazole Nitrate | 110 | 369.3 | 374.0 |
| Estradiol | 91 | 30.0 | 30.0 |
| Drs. Clotrimazole | 11 | 24.5 | 24.5 |
| Family Wellness Clotrimazole | 11 | 24.5 | 24.5 |
| Clotrimazole Topical | 11 | 24.5 | 24.5 |
| Clotrimazole | 11 | 23.0 | 23.0 |
| Conjugated Estrogens | 49 | 22.6 | 22.6 |
| Estrogens, Conjugated | 49 | 22.2 | 22.2 |
| Estradiol Gel 0.1% | 27 | 15.6 | 15.7 |
| Estradiol Transdermal | 27 | 15.6 | 15.6 |
| Copper | 10 | 5.9 | 6.0 |